EI
NXTM

EAM Investors’s NxStage Medical Inc. NXTM Stock Holding History

EAM Investors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-190,285
Closed -$4.17M – 385
2015
Q4 		$4.17M Buy
190,285
+41,220
+28% +$768K 0.55% 36
2015
Q3 		$2.35M Buy
+149,065
New +$2.39M 0.37% 119

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EAM Investors's NXTM Position: Q1 2016 in Review

EAM Investors sold out of NxStage Medical Inc. (NXTM) in Q1 2016, closing a stake of 190,285 shares — an estimated $4.17M sold.

EAM Investors first reported a position in NXTM in Q3 2015 and held it in 2 quarters. The position peaked at $4.17M in Q4 2015. 140 funds tracked by Wall St. Rank hold NXTM as of Q1 2016.

  • EAM Investors reported no remaining NxStage Medical Inc. position as of Q1 2016 after selling out during the quarter.
  • EAM Investors sold 190,285 NxStage Medical Inc. shares in Q1 2016, an estimated $4.17M.
  • EAM Investors first reported a position in NxStage Medical Inc. in Q3 2015 and held it in 2 quarters.
  • EAM Investors's NxStage Medical Inc. position peaked at $4.17M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2016.

Based on EAM Investors's 13F filing for Q1 2016, filed 16 May 2016.